(Journal Article): Cost-utility analysis of screening intervals for diabetic retinopathy in patients with type 2 diabetes mellitus.
Vijan S, Hofer TP, Hayward RA
IN:
JAMA
2000; 283(7):889-896
Impact Factor(s) of JAMA: 23.332 (2005), 24.831 (2004), 21.455 (2003), 17.569 (2001)